Monopar Therapeutics logo

Monopar Therapeutics

MNPR | NASDAQ
Chart Builder DCF Calculator
$71.97
-$0.03 (-0.04%)
At close: Nov 16, 2026, 4:00 PM ET
$71.97
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-0.04%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
23.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #959/1021 (Top 94%)

Key Statistics

Market Data

Market Cap $616.16M
1D Range
70.34 75.09
52W Range
50.12 123.84

Valuation (TTM)

PE -27.90
PB 4.85
EV/EBITDA -23.64

Valuation (NTM)

Forward PE N/A
Forward PEG -0.48
Price Target $125.00
Loading financial charts...

Profile

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage,...

Sector Healthcare
Industry Biotechnology
Employees 22
IPO Date Dec 19, 2019
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$125.00
Upside
+73.68%
Buy (4)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.